Establishment Labs Holdings Inc. Stock-Based Compensation
Establishment Labs Holdings Inc. (ESTA) reported Stock-Based Compensation of $6.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.23M, a 4.75% decline year-over-year.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.00M, a 23.38% increase year-over-year.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.90M, a 18.16% decline year-over-year.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.69M, a 26.53% decline year-over-year.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $11.41M, a 20.75% decline from fiscal 2024.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $14.40M, a 0.29% increase from fiscal 2023.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $14.36M, a 7.52% increase from fiscal 2022.
- Establishment Labs Holdings Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $13.36M, a 28.36% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.24M 10-Q · filed 2026-08-07 | $9.14M derived: sum of 3 quarters · filed 2026-08-07 | $11.82M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-08 | $5.91M derived: sum of 2 quarters · filed 2026-05-08 | $8.59M derived: sum of 3 quarters · filed 2026-05-08 | $11.98M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.59M derived: sum of 2 quarters · filed 2026-02-27 | $8.98M derived: sum of 3 quarters · filed 2026-08-07 | $11.41M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $6.08M derived: sum of 2 quarters · filed 2026-08-07 | $8.51M 10-Q · filed 2025-11-07 | $12.06M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.83M 10-Q · filed 2026-08-07 | $5.62M 10-Q · filed 2025-08-07 | $9.37M derived: sum of 3 quarters · filed 2026-08-07 | $13.03M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.43M 10-Q · filed 2026-05-08 | $5.98M derived: sum of 2 quarters · filed 2026-05-08 | $9.64M derived: sum of 3 quarters · filed 2026-05-08 | $13.39M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.20M derived: sum of 2 quarters · filed 2026-02-27 | $10.96M derived: sum of 3 quarters · filed 2026-02-27 | $14.40M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $7.41M derived: sum of 2 quarters · filed 2025-11-07 | $10.86M 10-Q · filed 2025-11-07 | $14.31M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $7.20M 10-Q · filed 2025-08-07 | $10.65M derived: sum of 3 quarters · filed 2026-02-27 | $14.62M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $3.44M 10-Q · filed 2025-05-09 | $6.89M derived: sum of 2 quarters · filed 2026-02-27 | $10.87M derived: sum of 3 quarters · filed 2026-02-27 | $14.48M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.42M derived: sum of 2 quarters · filed 2026-02-27 | $11.04M derived: sum of 3 quarters · filed 2026-02-27 | $14.36M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.59M derived: sum of 2 quarters · filed 2024-11-12 | $10.91M 10-Q · filed 2024-11-12 | $14.17M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.94M 10-Q · filed 2024-08-07 | $10.20M derived: sum of 3 quarters · filed 2025-02-28 | $13.12M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $3.32M 10-Q · filed 2024-05-09 | $6.58M derived: sum of 2 quarters · filed 2025-02-28 | $9.51M derived: sum of 3 quarters · filed 2025-02-28 | $13.25M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.18M derived: sum of 2 quarters · filed 2025-02-28 | $9.92M derived: sum of 3 quarters · filed 2025-02-28 | $13.36M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.66M derived: sum of 2 quarters · filed 2023-11-08 | $10.10M 10-Q · filed 2023-11-08 | $13.13M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2022-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.18M 10-Q · filed 2023-08-09 | $10.21M derived: sum of 3 quarters · filed 2024-03-04 | $13.27M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2022-03-31 | $3.43M 10-Q · filed 2023-05-10 | $6.46M derived: sum of 2 quarters · filed 2024-03-04 | $9.53M derived: sum of 3 quarters · filed 2024-03-04 | $12.09M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2021-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $6.09M derived: sum of 2 quarters · filed 2024-03-04 | $8.65M derived: sum of 3 quarters · filed 2024-03-04 | $10.41M 10-K · filed 2024-03-04 | |
| 2021-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.62M derived: sum of 2 quarters · filed 2022-11-09 | $7.38M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.31M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $1.76M 10-Q · filed 2022-05-10 | ||||
| 2020-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.90M derived: sum of 2 quarters · filed 2021-11-09 | $4.53M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $3.19M 10-Q · filed 2021-07-30 | |||
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-06 | ||||
| 2019-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.17M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $3.73M 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |